Background and Aims-It has been reported that eradication of Helicobacter pylon improves fold width in H pylon associated enlarged fold gastritis. The aim of this study was to clarify the mechanism of fold thickening in this condition. Patients and Methods-In eight patients with enlarged fold gastritis and 13 patients without enlarged folds, the presence of H pylori infection, inflammatory infiltrates, mucosal plasia, and epithelial cell proliferation in the body mucosa were investigated, and production of transforming growth factor a (TGFa), hepatocyte growth factor (HGF), and interleukin 1p (IL 1,) was determined by a competitive reverse transcription/polymerase chain reaction method and in vitro short-term culture ofbiopsy specimens. Results 
Enlarged folds in the gastric body are not an uncommon finding on radiographic or endoscopic examinations in adults. They are typically associated with a variety of diseases including hypertrophic gastritis, Menetrier's disease, Zollinger-Ellison syndrome, primary gastrin cell hyperplasia, carcinoma, and lymphoma.`2 As a special form of gastritis accompanied by mucosal hyperplasia of the stomach has been reported,3 inflammation of the gastric mucosa is thought to affect proliferation and differentiation of gastric epithelial cells. However, the mechanism by which inflammation of the gastric mucosa causes mucosal hyperplasia of the stomach is unknown.
Transforming growth factor ac (TGFa) and hepatocyte growth factor (HGF) are well known potent stimulators of gastric epithelial cell proliferation. 4 5 TGFa, which is produced by gastric epithelial cells, was reportedly overexpressed in the gastric mucosa of a patient with Menetrier's disease. 6 It also has been reported that TGFcx transgenic mice showed a number of features characteristic of Menetrier's disease. 7 Recently, HGF, which was originally identified as a growth factor for hepatocytes, has been shown to have the potential to stimulate growth of gastric epithelial cells.5 8 HGF production has been demonstrated by non-epithelial cells such as mesenchymal cells and granulocytes. 8-" Reportedly, HGF may be induced by interleukin 1, (IL 1 0), a cytokine that plays a key part in the inflammatory and immunological responses. [12] [13] [14] Recently, Helicobacter pylori has been well known as a cause of chronic active gastritis, '5 and it has been suggested that Hpylori gastritis may be one of the causes of enlarged gastric folds.'6 17 We have previously reported that eradication of H pylori improves inflammation of the gastric mucosa and fold width in Hpylori positive patients with enlarged folds; these findings suggest that H pylori infection may cause gastritis accompanied with enlarged folds -that is, 'enlarged fold gastritis'. '8 In agreement with our findings, improvement in fold thickening after eradication of H pylori has been reported by Stolte et 
Methods

Patients
We identified eight patients with enlarged fold gastritis (all H pylori positive) and 13 patients without enlarged folds (five H pylori positive and eight H pylori negative) ( Table I ). The group of eight patients demonstrated crowded, tortuous, and enlarged folds in the gastric body on a barium study performed as part of a mass screening for gastric carcinoma. Subsequently, they underwent endoscopic examination and were confirmed to have inflammation and H pylori colonisation of the body mucosa. The other group of 13 patients without enlarged folds underwent endoscopic examination because of complaints of dyspepsia; they were divided into two groups according to the presence or absence of H pylori infection. The width of the body fold was measured on double contrast radiographs in the supine position. Body folds were considered to be enlarged when the widest fold was greater than 5 mm according to the previous studies and the Sydney system.22 23 Measurement of mucosal andfoveolar thickness The mucosal and foveolar thicknesses of the body mucosa were measured on sections vertical to the mucosal surface using an image analysis system (Krypton-40, Flovel). Values were expressed as the mean of measurements along three or more different foveolae. Glandular thickness was calculated by subtracting foveolar thickness from mucosal thickness.
Assessment of epithelial cell proliferation Thin sections of 4% paraformaldehyde fixed tissues were immunostained for proliferating cells with monoclonal mouse anti-proliferating cell nuclear antigen (PCNA)27 (Dako-PCNA, PC 10) . Epithelial cell proliferation in the body mucosa was assessed by calculating the percentage of PCNA positive nuclei of the total nuclei in the glandular neck regions (PCNA labelling index) after counting at least 1000 total nuclei using the image analysis system.28 Immunostaining for PCNA was performed using a microwave assisted streptavidin-biotin peroxidase method.29 The anti-PCNA was used at a dilution of 1:50. The reaction was visualised using 3,3'-diaminobenzidine tetrachloride as a substrate. Negative control was used with mouse IgG instead of the anti-PCNA, and no detectable staining was seen.
Determination ofHGF and TGFa mRNA levels In five patients with enlarged fold gastritis, four H pylori positive and five H pylori negative patients without enlarged folds, HGF and TGFat mRNA levels in the body mucosa were determined by a competitive reverse transcription/polymerase chain reaction method in which rat mRNA was used as an internal standard.30 31 Total RNA was extracted from three biopsy specimens by the guanidinium thiocyanate/acid phenol methods.32 To obtain an internal standard, total RNA was extracted from rat stomach. To amplify HGF mRNA, we used two pairs of primers: the sequences were 5'-CCAATACCATTTGGAATGGA-3' for the first step 5' primer, 5'-CCA -TTACAACTC-GCAGTTG-3' primer. For the amplification of TGFo mRNA, two pairs of primers were used: the sequences were 5'-TGCCCAGATT-CCCACACTCA-3' for the first step 5' primer, 5'-TTCAGGAGGGCGCTGGGCTT-3' for the first step 3' primer, 5'-ACCTGCAGGTT-TTTGGTGGA-3' for the second step 5' primer and 5'-CGGCACCACTCACAGTG-3' for the second step 3' primer. To amplify 28S ribosomal RNA (rRNA), a pair of primers were used: the sequences were 5'-CCATGTGAA-CAGGAGTTGAA-3' for the 5' primer and 5'-CCCTGCCCTTCACAAAGAAA-3' for the 3' primer. Although both human and rat cDNAs originating from HGF mRNA, TGFoa mRNA and 28S rRNA were amplified by the same primers, only the human DNA fragments from HGF mRNA, TGFet mRNA, and 28S rRNA had the Bgl II, Eae I, and Eae I restriction endonuclease sites, respectively. The human and rat RNA mixtures were converted to cDNA with RA V-2 reverse transcriptase (Takara). Obtained cDNAs were amplified with respective primers and Thermus aquaticus DNA polymerase (Perkin-Elmer Cetus). The DNA fragments originating from HGF mRNA, TGFot mRNA, and 28S rRNA were digested with Bgl II (Nippon Gene), Eae I (Takara), and Eae I, respectively. Digested samples were separated into three peaks of DNA fragments using a high performance liquid chromatography column (TSK gel DEAE-NPR, 35 mmX4.6 mm internal diameter, Tosoh): two human fragments (smaller and larger) and a rat fragment. The peak height ratio of the larger human fragment to the rat fragment was used to determine the ratio of amplified DNA fragment from the human mRNA to that from the rat mRNA. As accurate quantitation of trace amounts of human total RNA obtained from biopsy specimens was difficult, the HGF or TGFot mRNA level was expressed as a relative HGF or TGFa mRNA/28S rRNA ratio.
In vitro short-term culture HGF and IL 11P release from the body mucosa were examined using in vitro short-term culture of biopsy specimens from the greater curvature of the upper portion of the body.33 After washing in 0.01 M phosphate buffered saline, four specimens were cultured in 1 ml of culture medium at 37°C in a 95% air and 5% CO2 humidified incubator for 24 hours. Culture medium consisted of RPMI 1640 (Research Foundation for Microbial Diseases of Osaka University) supplemented with 10% fetal bovine serum (BioWhittaker), 6 mg/l vancomycin hydrochloride (Sigma), and 2.5 mg/l amphotericin B (Sigma). Culture supernatants were collected, centrifuged at 10000 g, and stored at -80C until being assayed. The specimens were homogenised in 1 ml of 0.01 M phosphate buffered saline, and assayed for total protein concentration using the method involving bicinchoninic acid34 (BCA* Protein Assay Reagent, Pierce).
In seven patients with enlarged fold gastritis, HGF release from the body mucosa was examined in the presence and absence of 1 ig/ml of recombinant human IL 1 receptor antagonist35 (R&D Systems) using four biopsy specimens, respectively. It gastritis were significantly more severe than those in the H pylori negative patients without enlarged folds (p<00l) (Table II) . When the patients with enlarged fold gastritis were compared with the H pylon positive patients without enlarged folds, macrophage infiltration in the body mucosa was significantly more extensive in the patients with enlarged fold gastritis (p<005) (Fig 1) . When the H pylori positive patients without enlarged folds were compared with the H pylon negative patients without enlarged folds, both mononuclear and polymorphonuclear infiltrates were significantly more severe in the H pylori positive patients without enlarged folds (p<005 and p<OOl, respectively). Lymphocytic gastritis was not found in any patients.
Mucosal hyperplasia and epithelial cell proliferation In the patients with enlarged fold gastritis, the mucosal and foveolar thicknesses of the body mucosa were significantly greater than those in both the Hpylori positive and negative patients without enlarged folds (p<OO1) ( Table III) (Fig 2) . Glandular thickness, however, did not significantly differ among the three groups. The foveolar/glandular thickness ratio in the patients with enlarged fold gastritis was significantly higher than that in the H pylon negative patients without enlarged folds (p<O O1). There were no significant differences in mucosal, foveolar, and glandular thickness, and the foveolar/glandular thickness ratio between the H pylon positive and negative patients without enlarged folds. PCNA labelling indices in the body mucosa that were assessable in six patients with enlarged fold gastritis, one H pylon positive patient without enlarged folds, and four H pylori negative patients without enlarged folds, were 20-8 (2.7)%, 7.2%, and 9.0 (0O8)%, respectively. (Fig 3) . (Fig 6) .
Effects of eradication ofH pylori
After eradication ofHpylori in the patients with enlarged fold gastritis, the width of the body folds in the patients with enlarged fold gastnitis, which had been much greater than those in (Table II) . Mononuclear ..
--gand macrophage infiltrations also significantly decreased (p<005) (Figs 1 and 2 ), but mono--* --nuclear infiltrates remained in mild degrees. Mucosal and foveolar thicknesses, and the ---foveolar/glandular thickness ratio of the body mucosa also significantly decreased (p<005), r * 0.854 but glandular thickness did not significantly * p < 0.01 change (Table III) (Fig 2) . Mucosal and foveolar thicknesses after eradication were still | l greater than those in both the H pylori positive o 200 400 600 800 1000 and negative patients without enlarged folds IL 13 release (pg/24 hours/mg protein) (p<0. 01). Glandular thickness after eradication was greater than those in the H pylori negative patients without enlarged folds (p<0 01). The PCNA labelling index, which was assessable in B five patients, decreased significantly from 21.4 **-. (Fig 4) . a
Immunostainingfor HGF In the patients with enlarged fold gastritis before treatment, HGF immunoreactivity was abundantly present in the lamina propria, and observable mainly in polymorphonuclear cells and less frequently in comparatively large sized mononuclear cells with rich intracytoplasmic vesicles, which were thought to be macrophages (Fig 7) . After eradication of H pylori, HGF immunoreactivity was only sparsely present in the lamina propria, and observed only in the mononuclear cells. In the patients with Hpylori negative patients without enlarged folds, HGF immunoreactivity was observed in the small number of mononuclear cells.
Discussion
The results of this study indicate that patients with enlarged fold gastritis have extensive infiltrations of polymorphonuclear and mononuclear cells, especially macrophages, with H pylori colonisation in their gastric body mucosa. This study also demonstrates that mucosal thickness, especially foveolar thickness, of the body mucosa is increased in patients with enlarged fold gastritis. The mean mucosal and foveolar thicknesses of the patients in this study were compatible with the mucosal hyperplasia and profound foveolar hyperplasia previously reported.3 39 These results suggest that thickening of the gastric folds in enlarged fold gastritis is due to the combination of foveolar hyperplasia and intense inflammation in the lamina propria. This study further shows that epithelial cell proliferation in the body mucosa is increased in patients with enlarged fold gastritis, suggesting that foveolar hyperplasia in enlarged fold gastritis is due to increased epithelial cell proliferation. the H pylori positive and negative patients without enlarged folds (Table I) , significantly decreased from 1O.6 (0O6) mm to 7.1 (04) mm (p<005). However, fold width after eradi- subset of patients with H pylori gastritis such as those in this study. This may be dependent on the strain of Hpylori or immunological reactivity of the host. Decreased, but still raised, HGF release after eradication, despite the disappearance of polymorphonuclear cells, may reflect HGF production by activated macrophages that remained in the lamina propria.
Previously, we have reported that acid secretion is decreased in H pylori positive patients with enlarged fold gastritis.`5 Inhibition of acid secretion and increase in epithelial cell proliferation in patients with enlarged fold gastritis seem advantageous to the host because of reducing the mucosal injury caused by acid and pepsin, and promoting mucosal regeneration. However, it remains unclear whether the raised gastric pH may be for or against H pylori. On the other hand, chronic inflammation, hypochlorhydria, and longstanding epithelial cell hyperproliferation and hyperplastic state may be favourable to gastric carcinogenesis because of an increase in inflammatory mutagens, the intragastric formation of N-nitroso compounds, and the chance of mutation. Thus, further study is needed to clarify whether or not the risk of gastric carcinoma is increased in enlarged fold gastritis, and eradication of Hpylori reduces the risk.
